Cartesian Growth Stock Performance
| RENEU Stock | USD 11.63 0.25 2.20% |
Cartesian Growth has a performance score of 9 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.0366, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cartesian Growth's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cartesian Growth is expected to be smaller as well. Cartesian Growth right now shows a risk of 0.27%. Please confirm Cartesian Growth total risk alpha, rate of daily change, as well as the relationship between the Rate Of Daily Change and period momentum indicator , to decide if Cartesian Growth will be following its price patterns.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Cartesian Growth are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, Cartesian Growth is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors. ...more
Actual Historical Performance (%)
Year To Date Return 6.02 | Ten Year Return 16.07 | All Time Return 16.07 |
1 | Berkley W R Corp Acquires 128,947 Shares of Cartesian Growth Co. II - MarketBeat | 09/24/2024 |
2 | Westchester Capital Management Bolsters Position in Cartesian Gr - GuruFocus.com | 11/14/2024 |
3 | Timothy Springer Bought 4.9 percent More Shares In Cartesian Therapeutics - Simply Wall St | 11/21/2024 |
| Begin Period Cash Flow | 543.7 K |
Cartesian |
Cartesian Growth Relative Risk vs. Return Landscape
If you would invest 1,138 in Cartesian Growth on September 12, 2024 and sell it today you would earn a total of 25.00 from holding Cartesian Growth or generate 2.2% return on investment over 90 days. Cartesian Growth is currently producing 0.0343% returns and takes up 0.2746% volatility of returns over 90 trading days. Put another way, 2% of traded stocks are less volatile than Cartesian, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Cartesian Growth Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cartesian Growth's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Cartesian Growth, and traders can use it to determine the average amount a Cartesian Growth's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.125
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | RENEU |
Estimated Market Risk
| 0.27 actual daily | 2 98% of assets are more volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Cartesian Growth is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cartesian Growth by adding it to a well-diversified portfolio.
Cartesian Growth Fundamentals Growth
Cartesian Stock prices reflect investors' perceptions of the future prospects and financial health of Cartesian Growth, and Cartesian Growth fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cartesian Stock performance.
| Return On Asset | -0.0056 | ||||
| Current Valuation | 251.14 M | ||||
| EBITDA | 11.44 M | ||||
| Net Income | 11.44 M | ||||
| Cash And Equivalents | 814.17 K | ||||
| Cash Per Share | 0.03 X | ||||
| Total Debt | 3.98 M | ||||
| Book Value Per Share | (0.86) X | ||||
| Cash Flow From Operations | (922.74 K) | ||||
| Total Asset | 174.58 M | ||||
| Retained Earnings | (18.54 M) | ||||
| Working Capital | (1.2 M) | ||||
About Cartesian Growth Performance
Assessing Cartesian Growth's fundamental ratios provides investors with valuable insights into Cartesian Growth's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Cartesian Growth is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.07 | 0.07 | |
| Return On Capital Employed | (0.01) | (0.01) | |
| Return On Assets | 0.07 | 0.07 | |
| Return On Equity | 0.07 | 0.08 |
Things to note about Cartesian Growth performance evaluation
Checking the ongoing alerts about Cartesian Growth for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cartesian Growth help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cartesian Growth has high likelihood to experience some financial distress in the next 2 years | |
| Cartesian Growth has accumulated about 814.17 K in cash with (922.74 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.03. | |
| Latest headline from news.google.com: Timothy Springer Bought 4.9 percent More Shares In Cartesian Therapeutics - Simply Wall St |
- Analyzing Cartesian Growth's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cartesian Growth's stock is overvalued or undervalued compared to its peers.
- Examining Cartesian Growth's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cartesian Growth's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cartesian Growth's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cartesian Growth's stock. These opinions can provide insight into Cartesian Growth's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Cartesian Stock Analysis
When running Cartesian Growth's price analysis, check to measure Cartesian Growth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cartesian Growth is operating at the current time. Most of Cartesian Growth's value examination focuses on studying past and present price action to predict the probability of Cartesian Growth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cartesian Growth's price. Additionally, you may evaluate how the addition of Cartesian Growth to your portfolios can decrease your overall portfolio volatility.